4.4 Article

Ventricular arrhythmias and sudden cardiac arrest in Takotsubo cardiomyopathy: Incidence, predictive factors, and clinical implications

Journal

HEART RHYTHM
Volume 15, Issue 8, Pages 1171-1178

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.hrthm.2018.04.002

Keywords

Cardiac arrest; Complete atrioventricular block; Takotsubo cardiomyopathy; Ventricular fibrillation; Ventricular tachycardia

Ask authors/readers for more resources

BACKGROUND Takotsubo cardiomyopathy (TTC) is a stress-related transient cardiomyopathy. Life-threatening arrhythmias (LTA) can occur and worsen prognosis. OBJECTIVE The purpose of this study was to assess the incidence and outcome of LTA in TTC, as well as its predictive factors and clinical implications. METHODS We studied 214 consecutive cases of TTC over 8 years. The study cohort was divided into 2 groups: those with LTA (LTA group) and those without (non-LTA group). LTA was defined as ventricular tachycardia, ventricular fibrillation, or cardiac arrest. RESULTS LTA occurred in 23 (10.7%) of patients mainly in the first 24 hours of hospitalization: ventricular tachycardia (n = 2), ventricular fibrillation (n = 11), cardiac arrest (n = 10: 5 asystole, 3 complete heart block, and 2 sinoatrial block). LTAs were associated with lower left ventricular ejection fraction (LVEF) and a high rate of conduction disturbances. In-hospital (39.1% vs 8.9%; P < .001) and 1-year mortality (47.8% vs 14.1%; P < .001) rates were significantly increased in the LTA group. LVEF and QRS duration >105 ms were independent predictors of LTA. In cases where a device was implanted, conduction disturbances persisted after the index event despite complete recovery of LVEF. There was no ventricular arrhythmia recurrence during follow-up. CONCLUSION LTAs occur early in patients presenting with TTC and are associated with significantly worse short-and long-term prognosis. Left ventricular impairment and QRS duration >105 ms are independent predictors of LTA. Ventricular arrhythmias occurred in the acute phase without further recurrence recorded in hospital survivors, whereas severe conduction disorders persisted during long-term follow-up. These findings may have implications on the choice of device therapy for this specific patient subgroup.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Letter Cardiac & Cardiovascular Systems

Transient endothelial injury and release of lupus anticoagulant in COVID-19

Antonin Trimaille, Benjamin Marchandot, Walid Oulehri, Adrien Carmona, Olivier Vollmer, Vincent Poindron, Kensuke Matsushita, Laurent Sattler, Lelia Grunebaum, Anne-Sophie Korganow, Valerie Schini-Kerth, Olivier Morel

JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2022)

Editorial Material Cardiac & Cardiovascular Systems

Acute Right Ventricular Failure and Right-to-Left Shunt Due to Massive Coronary Air Embolism Following MitraClip

Kensuke Matsushita, Marion Kibler, Floriane Zeyons, Sebastien Hess, Olivier Morel, Patrick Ohlmann

CANADIAN JOURNAL OF CARDIOLOGY (2022)

Review Hematology

Role of neutrophils, platelets, and extracellular vesicles and their interactions in COVID-19-associated thrombopathy

Antoine Caillon, Antonin Trimaille, Julie Favre, Laurence Jesel, Olivier Morel, Gilles Kauffenstein

Summary: This study explores the impact of neutrophils, platelets, and extracellular vesicles on the thromboinflammatory process in COVID-19 patients. The article emphasizes the crucial role of the immune system in inflammation and thrombosis, and discusses potential therapeutic strategies focusing on modulating purinergic signaling.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2022)

Letter Cardiac & Cardiovascular Systems

Time to consider neuroinflammation as a booster effect of cerebral venous sinus thrombosis in vaccine-induced immune thrombotic thrombocytopenia?

Benjamin Marchandot, Adrien Carmona, Olivier Morel

JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2022)

Article Medicine, General & Internal

Impact of Primary Hemostasis Disorders on Late Major Bleeding Events among Anticoagulated Atrial Fibrillation Patients Treated by TAVR

Laurent Dietrich, Marion Kibler, Kensuke Matsushita, Benjamin Marchandot, Antonin Trimaille, Antje Reydel, Bamba Diop, Phi Dinh Truong, Anh Mai Trung, Annie Trinh, Adrien Carmona, Sebastien Hess, Laurence Jesel, Patrick Ohlmann, Olivier Morel

Summary: This study evaluated the impact of ongoing primary hemostasis disorders among anticoagulated AF patients after TAVR. It found that a post-procedural CT-ADP > 180 s was identified as a strong independent predictor of late major/life-threatening bleeding complications. These findings suggest that persistent primary hemostasis disorders contribute to a higher risk of late bleeding events.

JOURNAL OF CLINICAL MEDICINE (2022)

Article Cardiac & Cardiovascular Systems

Apixaban vs. standard of care after transcatheter aortic valve implantation: the ATLANTIS trial

Jean-Philippe Collet, Eric Van Belle, Holger Thiele, Sergio Berti, Thibault Lhermusier, Thibault Manigold, Franz-Josef Neumann, Martine Gilard, David Attias, Farzin Beygui, Angel Cequier, Fernando Alfonso, Pierre Aubry, Flore Baronnet, Stephane Ederhy, Mohamad El Kasty, Mathieu Kerneis, Olivier Barthelemy, Thierry Lefevre, Pascal Leprince, Alban Redheuil, Patrick Henry, Jean-Jacques Portal, Eric Vicaut, Gilles Montalescot

Summary: This study aimed to compare the effectiveness of oral anticoagulation and antiplatelet therapy after TAVI surgery and found that apixaban was not superior to standard treatment, regardless of the indication for oral anticoagulation.

EUROPEAN HEART JOURNAL (2022)

Article Cardiac & Cardiovascular Systems

P2Y12 inhibition by clopidogrel increases adverse clinical events after transcatheter aortic valve replacement

Kensuke Matsushita, Benjamin Marchandot, Marion Kibler, Joe Heger, Marilou Peillex, Antonin Trimaille, Sebastien Hess, Lelia Grunebaum, Mickael Ohana, Antje Reydel, Laurence Jesel, Patrick Ohlmann, Olivier Morel

Summary: Appropriate P2Y12 inhibition by clopidogrel is a major determinant of MACCE at 90 days after TAVR.

INTERNATIONAL JOURNAL OF CARDIOLOGY (2022)

Article Cardiac & Cardiovascular Systems

Transcatheter aortic valve implantation using the SAPIEN 3 valve to treat aortic regurgitation: The French multicentre S3AR study

Clemence Delhomme, Marina Urena, Oualid Zouaghi, Francisco Campelo-Parada, Patrick Ohlmann, Gilles Rioufol, Eric Van Belle, Frederic Pinaud, Nicolas Meneveau, Patrick Staat, Olivier Morel, Francois Derimay, Flavien Vincent, Frederic Rouleau, Eric Brochet, Caroline Chong-Nguyen, Dominique Himbert

Summary: This study evaluated the effectiveness of transcatheter aortic valve implantation using the SAPIEN 3 transcatheter heart valve in patients with pure aortic regurgitation. The results showed a device success rate of 94.6%, a 30-day all-cause mortality rate of 8.1%, and a one-year all-cause mortality rate of 16.2%. This method appears promising for treating high-risk patients with pure aortic regurgitation, but further research is needed.

ARCHIVES OF CARDIOVASCULAR DISEASES (2023)

Letter Cardiac & Cardiovascular Systems

Oral Anticoagulant Dose Adjustment After TAVR

Kensuke Matsushita, Antonin Trimaille, Benjamin Marchandot, Patrick Ohlmann, Olivier Morel

JACC-CARDIOVASCULAR INTERVENTIONS (2022)

Editorial Material Cardiac & Cardiovascular Systems

Modulation of inflammatory response after myocardial infarction: one explanation for the cardiovascular benefit of empagliflozin in the EMMY trial?

Antonin Trimaille, Benjamin Marchandot, Olivier Morel

EUROPEAN HEART JOURNAL (2023)

Letter Cardiac & Cardiovascular Systems

Letter regarding the article 'Acute heart failure after non-cardiac surgery: incidence, phenotypes, determinants and outcomes'

Benjamin Marchandot, Antonin Trimaille, Olivier Morel

EUROPEAN JOURNAL OF HEART FAILURE (2023)

Article Medicine, General & Internal

Occurrence of Severe Arrhythmias in Patients with Non-ST Elevation Acute Coronary Syndrome (NSTE-ACS): A Retrospective Study

Valerie Wilme, Sebastien Harscoat, Francois Severac, Adrien Carmona, Pierrick Le Borgne, Pascal Bilbault, Olivier Morel, Sabrina Kepka

Summary: This retrospective single-center study aimed to estimate the frequency of serious heart rhythm disorders (SHRDs) among 480 patients with non-ST elevation acute coronary syndrome (NSTE-ACS) and identify associated factors. The results showed that the occurrence rate of SHRDs during the first 48 hours of hospital care was 2.3%, with 0.4% of patients requiring immediate treatment and no deaths. Age, anticoagulant medication, decreased glomerular filtration rate, decreased hemoglobin and left ventricle ejection fraction (LVEF), and increased troponin, BNP, and CRP levels were significantly associated with SHRDs. Higher hemoglobin level (>12 g/dL) appeared to be a protective factor for SHRDs.

JOURNAL OF CLINICAL MEDICINE (2023)

Review Cardiac & Cardiovascular Systems

Contemporary issues and lifetime management in patients underwent transcatheter aortic valve replacement

Kensuke Matsushita, Olivier Morel, Patrick Ohlmann

Summary: The latest clinical trials have shown positive outcomes of TAVR in low surgical risk patients with severe aortic stenosis. However, there are unresolved concerns for younger patients with longer life expectancy. Factors such as prosthesis-patient mismatch, heart failure hospitalization, subclinical thrombosis, future coronary access, and valve durability can affect long-term clinical outcomes. This review examines the available evidence and discusses potential treatment strategies for the lifetime management of TAVR patients.

CARDIOVASCULAR INTERVENTION AND THERAPEUTICS (2023)

Article Cardiac & Cardiovascular Systems

Coronary subclavian steal syndrome causing acute coronary syndrome: a case report

Adrien Carmona, Benjamin Marchandot, Mylene Sagnard, Olivier Morel

Summary: This case highlights the complexity of cardio-renal interaction in patients with CSSS causing ACS. Revascularization of the proximal left subclavian artery with a stent was performed, enabling instant recovery of distal coronary flows. Treatment options for CSSS include secondary prevention measures and revascularization through endovascular approaches if indicated.

EUROPEAN HEART JOURNAL-CASE REPORTS (2022)

No Data Available